Laura A. McClure
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Laura A. McClure.
Drug and Alcohol Dependence | 2013
Noella A. Dietz; David F. Sly; David J. Lee; Kristopher L. Arheart; Laura A. McClure
BACKGROUND Young adults (18-24 years) have the highest smoking rate of any age group. Unlike youth/adult populations where there is one primary message targeting behavior, anti-tobacco campaigns targeting young adults should contain messages of prevention and cessation. The objective was to identify factors influencing young adult cigarette use, employing the Centers for Disease Control and Prevention logic model, with an emphasis on the role of lifestyle, tobacco use tolerance, and attitudes/beliefs. METHODS Cross-sectional data were collected from 4401 young adults using telephone interviews in 2010 as part of the evaluation for the Tobacco Free Florida Campaign. Multivariate logistic regression was used to examine the relationship between current smoking status and lifestyles, tolerance of tobacco use, and attitude/belief variables. RESULTS The young adult cigarette prevalence rate is 20.3%, with males more likely to be smokers (25.1%) than females (15.6%) and non-Hispanic Whites more likely to be smokers than other racial/ethnic groups (23.8%). Significant associations were found between lifestyle variables (frequent bar/club, drinks per month, and number of friends who smoke), tolerance of tobacco use (allow smoke in house/car and moderate tobacco use), and four attitude/belief indices and current smoking behavior. CONCLUSIONS Results suggest lifestyles and attitudes/beliefs should be key behavioral targets of prevention programs aimed at young adults. Data strongly suggest that as young adults reject negative labels attached to smokers, they are more likely to smoke. Prevention (and cessation) programs may need to reduce barriers that result in segregating nonsmokers/smokers so smokers can have an increased chance of adopting attitudes/beliefs of nonsmokers.
Cornea | 2012
Anat Galor; D. Diane Zheng; Kristopher L. Arheart; Byron L. Lam; Victor L. Perez; Kathryn E. McCollister; Manuel A. Ocasio; Laura A. McClure; David Lee
Purpose: To study dry eye medication use and expenditures from 2001 to 2006 using a nationally representative sample of US adults. Methods: This study retrospectively analyzed dry eye medication use and expenditures of participants of the 2001 to 2006 Medical Expenditure Panel Survey, a nationally representative subsample of the National Health Interview Survey. After adjusting for survey design and for inflation using the 2009 inflation index, data from 147 unique participants aged 18 years or older using the prescription medications Restasis and Blephamide were analyzed. The main outcome measures were dry eye medication use and expenditures from 2001 to 2006. Results: Dry eye medication use and expenditures increased between the years 2001 and 2006, with the mean expenditure per patient per year being
Preventing Chronic Disease | 2017
Diana Kachan; Henry A. Olano; Stacey L. Tannenbaum; Debra W. Annane; Ashwin Mehta; Kristopher L. Arheart; Lora E. Fleming; Xuan Yang; Laura A. McClure; David Lee
55 in 2001 to 2002 (n = 29),
Investigative Ophthalmology & Visual Science | 2014
D. Diane Zheng; Sharon L. Christ; Byron L. Lam; Stacey L. Tannenbaum; Christine L. Bokman; Kristopher L. Arheart; Laura A. McClure; Cristina A. Fernandez; David J. Lee
137 in 2003 to 2004 (n = 32), and
Preventing Chronic Disease | 2014
Diana Kachan; Stacey L. Tannenbaum; Henry A. Olano; William G. LeBlanc; Laura A. McClure; David Lee
299 in 2005 to 2006 (n = 86). This finding was strongly driven by the introduction of topical cyclosporine emulsion 0.05% (Restasis; Allergan, Irvine, CA). In analysis pooled over all survey years, demographic factors associated with dry eye medication expenditures included gender (female:
Journal of Physical Activity and Health | 2016
Stacey L. Tannenbaum; Laura A. McClure; Taghrid Asfar; Recinda Sherman; William G. LeBlanc; David Lee
244 vs. male:
Preventive Medicine | 2013
Laura A. McClure; Kristopher L. Arheart; David J. Lee; David F. Sly; Noella A. Dietz
122, P < 0.0001), ethnicity (non-Hispanic:
Addictive Behaviors | 2013
Laura A. McClure; Cristina A. Fernandez; Tainya C. Clarke; William G. LeBlanc; Kristopher L. Arheart; Lora E. Fleming; David J. Lee
228 vs. Hispanic:
BMJ open diabetes research & care | 2016
Stacey L. Tannenbaum; Laura A. McClure; D. Diane Zheng; Byron L. Lam; Kristopher L. Arheart; Charlotte E. Joslin; Gregory A. Talavera; David J. Lee
106, P < 0.0001), and education (greater than high school:
Preventing Chronic Disease | 2012
Stacey L. Tannenbaum; Diana Kachan; Cristina A. Fernandez; Laura A. McClure; William G. LeBlanc; Kristopher L. Arheart; David Lee
250 vs. less than high school: